SAHMRI response to COVID-19

19 Mar 2020
SAHMRI response to COVID-19

In the face of the situation brought about by COVID-19, SAHMRI is committed to the best interests of its staff and broader community but also our responsibilities to other partners and clients.

Business continuity

SAHMRI plays an important role as a partner, supplier and collaborator with a range of organisations. We have already put measures in place to ensure business continuity across product and service providers including, but not limited to:

  • Core Facilities
  • Research Support Services
  • Molecular Imaging and Therapy Research Unit
  • Bioresources and Preclinical, Imaging and Research Laboratories
  • Loading bay

We have contingencies planned to maintain business continuity despite changing circumstances and will communicate any changes if there are interruptions to normal activities.

Public access

Tours of SAHMRI and public events at SAHMRI have been postponed or cancelled until further notice with swipe-card access now applying to all entrances. The café on Level 4 of SAHMRI’s North Terrace building has been closed to the public.

Alternative arrangements have been made for non-essential clinic and clinical trial visits while extra hygiene precautions are in place for patients and participants who still need to attend in person.

Visitors who need access to SAHMRI facilities should report to reception or contact the person they are meeting directly.  

Further information

For further information please contact:

Pete McDonald
Head of Media and Communications
M: 0402 293 078
E: pete.mcdonald@sahmri.com